Table 3.

Characteristics and outcomes of pregnant women with confirmed drug-resistant tuberculosis (n=8)

Participant	Age	TB Presentation	Baseline DST profile	TB treatment regimen	Treatment Outcome
1	19	• Smear +++ pulmonary TB • No history of TB • Cavity seen on CXR • Cough, cough with blood, cough with phlegm, weight loss, difficulty breathing	MDR (Resistant: INH, RIF, SM)	CS EMB ETH LEVO PZA	Treatment completed
2	21	• Smear + pulmonary TB • History of TB • Cough, cough with phlegm, difficulty breathing, night sweats	MDR (Resistant: INH, RIF, SM)	CS EMB ETH LEVO PZA	Lost to follow up
3	29	• Smear – pulmonary TB • No history of TB • Cough, cough with blood, cough with phlegm, difficulty breathing, night sweats	Mono-resistant (Resistant SM)	EMB INH PZA RIF	Cured
4	30	• Smear – pulmonary TB • No history of TB • Cough, cough with blood, cough with phlegm, weight loss, difficulty breathing, night sweats	Mono-resistant (Resistant: EMB)	EMB INH PZA RIF	Cured
5	34	• Smear ++ pulmonary TB • History of TB • Cough, cough with phlegm, weight loss	MDR (Resistant: PZA, INH, EMB, RIF, SM)	CS LEVO PAS PZA	Cured
6	17	• Smear ++ pulmonary TB • No history of TB • History of asthma • Difficulty breathing, night sweats	Mono-resistant (Resistant: SM)	EMB INH LEVO PZA	Cured
7	33	• Smear + pulmonary TB • History of TB • Cough, cough with phlegm, weight loss	Mono-resistant (Resistant: RIF)a	EMB INH PZA RIF	Cured
8	25	• Smear +++ pulmonary TB • No history of TB • Cough, cough with blood, cough with phlegm, weight loss	MDR (Resistant: INH, EMB, RIF, SM)	EMB INH PZA RIF	Treatment completed

Abbreviations: CXR chest x-ray, CS cycloserine, EMB ethambutol, ETH ethionamide, LEVO levofloxacin, PZA pyrazinamide, INH isoniazid, RIF rifampin, SM streptomycin

^aRIF resistance was detected on a second drug susceptible test